Delix Therapeutics

Delix Therapeutics, Inc. ("Delix")
Company typePrivate
Industry
Founded2019
HeadquartersBoston, Massachusetts
Key people
Mark Rus (Chief Executive Officer)
Websitedelixtherapeutics.com

Delix Therapeutics is an American biotech company based in Boston, Massachusetts. The company develops novel neuroplasticity-promoting therapeutics for central nervous system (CNS) diseases such as depression and post-traumatic stress disorder (PTSD). It was co-founded in 2019 by David E. Olson and Nick Haft.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.